DEC 05, 2018 09:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Making the most of your mouse model with bead-based multiplexing

SPONSORED BY: Luminex
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Proteomics Field Application Scientist Leader, Bio-Rad Laboratories
    Biography
      Dr. Daniel Braunschweig received his PhD in Immunology from the University of California, Davis, studying the role of the immune system in autism. He subsequently published more than 15 peer-reviewed articles on the interface between neurodevelopment and immunology, with an emphasis on emerging immunoassay techniques. Dr. Braunschweig has held a variety of positions in the Biotechnology field, and currently leads a team of Field Application Scientists focused on assisting researchers with protein purification and immunoassays.

    Abstract:

    DATE: December 5, 2018
    TIME:  9:00AM PST

    The mouse is a critical, increasingly used model system in biomedical research and preclinical drug discovery. While technological advances enable complex genetic manipulations that result in increased translational relevance, one distinct limitation remains - sample volume.

    In addition, preclinical research increasingly demands measurement of multiple biomarkers (cytokines, chemokines, and growth factors) to characterize signaling pathways accurately or to analyze the effects of an intervention. Unfortunately, researches are often forced to design experiments around sample limitations.

    The Bio-Plex® Multiplex System, powered by Luminex xMAP® Technology enables the quantification of more than 500 different protein or peptide targets simultaneously from a single sample volume. More specifically, the Bio-Plex Pro™ Mouse Cytokine, Chemokine, and Growth Factor Magnetic Bead-Based Assays detect and measure levels of 46 analytes in diverse matrices such as serum, plasma, and tissue culture supernatants.

    This presentation will provide an overview of multiplexing technology for research use with mouse samples, and highlight the associated benefits to the drug discovery workflow.

     

    Learning Objectives:

    • What xMAP Technology is and how it is used
    • Mouse models in research
    • Common challenges and solutions with multiplexing technology
    • Features of xMAP-based multiplexing vs. other options for quantitation:

              - Reduced sample volume usage

              - Enhanced dynamic range and quantitation in contrast to ELISA

              - Global profiling and pathway analysis

              - Increased throughput capabilities coupled with reduced cost and time inputs

              - Superior data accuracy


    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    Loading Comments...